Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-109 |
Sentence |
denotes |
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. |
T1 |
0-109 |
Sentence |
denotes |
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. |
TextSentencer_T2 |
110-277 |
Sentence |
denotes |
Human immunodeficiency virus type 1 (HIV-1) entry is mediated by the interaction between a variably glycosylated envelope glycoprotein (gp120) and host-cell receptors. |
T2 |
110-277 |
Sentence |
denotes |
Human immunodeficiency virus type 1 (HIV-1) entry is mediated by the interaction between a variably glycosylated envelope glycoprotein (gp120) and host-cell receptors. |
TextSentencer_T3 |
278-436 |
Sentence |
denotes |
Approximately half of the molecular mass of gp120 is contributed by N-glycans, which serve as potential epitopes and may shield gp120 from immune recognition. |
T3 |
278-436 |
Sentence |
denotes |
Approximately half of the molecular mass of gp120 is contributed by N-glycans, which serve as potential epitopes and may shield gp120 from immune recognition. |
TextSentencer_T4 |
437-560 |
Sentence |
denotes |
The role of gp120 glycans in the host immune response to HIV-1 has not been comprehensively studied at the molecular level. |
T4 |
437-560 |
Sentence |
denotes |
The role of gp120 glycans in the host immune response to HIV-1 has not been comprehensively studied at the molecular level. |
TextSentencer_T5 |
561-737 |
Sentence |
denotes |
We developed a new approach to characterize cell-specific gp120 glycosylation, the regulation of glycosylation, and the effect of variable glycosylation on antibody reactivity. |
T5 |
561-737 |
Sentence |
denotes |
We developed a new approach to characterize cell-specific gp120 glycosylation, the regulation of glycosylation, and the effect of variable glycosylation on antibody reactivity. |
TextSentencer_T6 |
738-914 |
Sentence |
denotes |
A model oligomeric gp120 was expressed in different cell types, including cell lines that represent host-infected cells or cells used to produce gp120 for vaccination purposes. |
T6 |
738-914 |
Sentence |
denotes |
A model oligomeric gp120 was expressed in different cell types, including cell lines that represent host-infected cells or cells used to produce gp120 for vaccination purposes. |
TextSentencer_T7 |
915-1048 |
Sentence |
denotes |
N-Glycosylation of gp120 varied, depending on the cell type used for its expression and the metabolic manipulation during expression. |
T7 |
915-1048 |
Sentence |
denotes |
N-Glycosylation of gp120 varied, depending on the cell type used for its expression and the metabolic manipulation during expression. |
TextSentencer_T8 |
1049-1180 |
Sentence |
denotes |
The resultant glycosylation included changes in the ratio of high-mannose to complex N-glycans, terminal decoration, and branching. |
T8 |
1049-1180 |
Sentence |
denotes |
The resultant glycosylation included changes in the ratio of high-mannose to complex N-glycans, terminal decoration, and branching. |
TextSentencer_T9 |
1181-1313 |
Sentence |
denotes |
Differential glycosylation of gp120 affected envelope recognition by polyclonal antibodies from the sera of HIV-1-infected subjects. |
T9 |
1181-1313 |
Sentence |
denotes |
Differential glycosylation of gp120 affected envelope recognition by polyclonal antibodies from the sera of HIV-1-infected subjects. |
TextSentencer_T10 |
1314-1439 |
Sentence |
denotes |
These results indicate that gp120 glycans contribute to antibody reactivity and should be considered in HIV-1 vaccine design. |
T10 |
1314-1439 |
Sentence |
denotes |
These results indicate that gp120 glycans contribute to antibody reactivity and should be considered in HIV-1 vaccine design. |